2 June 2017 – directors’ dealing
The Chairman and CEO have both bought shares in the company with the former buying 18,500 shares at 133.7p and the latter picking up 44,578 shares at a price of 133.898p. We believe this is further confirmation that recovery at the group remains on track and we re-iterate our recommendation of BUY.